• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羊水来源的干细胞作为分泌的血管生成因子的储存库,能够刺激缺血模型中的新血管生成。

Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model.

机构信息

Department of Oncology, Biology and Genetics, University of Genoa, Largo Rosanna Benzi 10, 16132 Genova, Italy.

出版信息

Biomaterials. 2011 May;32(15):3689-99. doi: 10.1016/j.biomaterials.2011.01.071. Epub 2011 Mar 2.

DOI:10.1016/j.biomaterials.2011.01.071
PMID:21371750
Abstract

Most urgent health problems are related to a blood vessel formation failure. The use of stem cells from different sources or species for both in vitro and in vivo engineering of endothelium does not necessarily imply their direct commitment towards a vascular phenotype. In the present study, we used human amniotic fluid stem cells (AFSC) to evoke a strong angiogenic response in murine recipients, in terms of host guided-regeneration of new vessels, and we demonstrated that the AFSC secretome is responsible for the vascularising properties of these cells. We indentified in AFSC conditioned media (ACM) pro-angiogenic soluble factors, such as MCP-1, IL-8, SDF-1, VEGF. Our in vitro results suggest that ACM are cytoprotective, pro-differentiative and chemoattractive for endothelial cells. We also tested ACM on a pre-clinical model of hind-limb ischemic mouse, concluding that ACM contain mediators that promote the neo-arteriogenesis, as remodelling of pre-existing collateral arteries to conductance vessels, thus preventing the capillary loss and the tissue necrosis of distal muscles. In line with the current regenerative medicine trend, in the present study we assert the concept that stem cell-secreted mediators can guide the tissue repair by stimulating or recruiting host reparative cells.

摘要

大多数紧急的健康问题都与血管生成失败有关。使用来自不同来源或物种的干细胞进行体外和体内内皮工程,并不一定意味着它们直接朝着血管表型发展。在本研究中,我们使用人羊水干细胞(AFSC)在小鼠受体内引发强烈的血管生成反应,表现为宿主引导的新血管再生,我们证明了 AFSC 分泌组是这些细胞血管生成特性的原因。我们在 AFSC 条件培养基(ACM)中鉴定出了促血管生成的可溶性因子,如 MCP-1、IL-8、SDF-1 和 VEGF。我们的体外结果表明,ACM 对内皮细胞具有细胞保护、促分化和趋化作用。我们还在小鼠后肢缺血的临床前模型上测试了 ACM,得出结论 ACM 中含有促进新动脉生成的介质,即重塑预先存在的侧支动脉为传导血管,从而防止远端肌肉的毛细血管损失和组织坏死。与当前再生医学的趋势一致,在本研究中,我们主张干细胞分泌的介质可以通过刺激或招募宿主修复细胞来引导组织修复的概念。

相似文献

1
Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model.羊水来源的干细胞作为分泌的血管生成因子的储存库,能够刺激缺血模型中的新血管生成。
Biomaterials. 2011 May;32(15):3689-99. doi: 10.1016/j.biomaterials.2011.01.071. Epub 2011 Mar 2.
2
Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap.羊膜干细胞来源的促血管生成可溶性因子在缺血性筋膜皮瓣模型中募集内皮祖细胞。
Stem Cells Dev. 2012 Aug 10;21(12):2179-88. doi: 10.1089/scd.2011.0639. Epub 2012 Mar 6.
3
Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis.异体移植人羊膜来源干细胞作为治疗性血管生成的细胞来源。
Int J Cardiol. 2013 Sep 20;168(1):66-75. doi: 10.1016/j.ijcard.2012.09.072. Epub 2012 Oct 6.
4
Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model.凝血酶可促进兔后肢缺血模型中的动脉生成和血流动力学恢复。
J Vasc Surg. 2009 Apr;49(4):1000-12. doi: 10.1016/j.jvs.2008.11.004. Epub 2009 Feb 14.
5
Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.纳米颗粒介导的匹伐他汀内皮细胞选择性递送至慢性后肢缺血兔模型中诱导功能性侧支动脉形成(治疗性血管生成)。
J Vasc Surg. 2010 Aug;52(2):412-20. doi: 10.1016/j.jvs.2010.03.020. Epub 2010 Jun 22.
6
The pre-vascularisation of a collagen-chondroitin sulphate scaffold using human amniotic fluid-derived stem cells to enhance and stabilise endothelial cell-mediated vessel formation.使用人羊水来源干细胞对硫酸软骨素胶原蛋白支架进行血管预构建,以增强和稳定内皮细胞介导的血管形成。
Acta Biomater. 2015 Oct;26:263-73. doi: 10.1016/j.actbio.2015.08.030. Epub 2015 Aug 20.
7
Hypoxia-induced amniotic fluid stem cell secretome augments cardiomyocyte proliferation and enhances cardioprotective effects under hypoxic-ischemic conditions.缺氧诱导的羊水干细胞分泌组增强心肌细胞增殖,并在缺氧缺血条件下增强心脏保护作用。
Sci Rep. 2021 Jan 8;11(1):163. doi: 10.1038/s41598-020-80326-w.
8
Capillary-like network formation by human amniotic fluid-derived stem cells within fibrin/poly(ethylene glycol) hydrogels.人羊水来源干细胞在纤维蛋白/聚乙二醇水凝胶内形成类毛细血管网络。
Tissue Eng Part A. 2015 Apr;21(7-8):1185-94. doi: 10.1089/ten.TEA.2014.0288. Epub 2015 Jan 28.
9
Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo.人多能干细胞来源的成纤维细胞在体外和体内激活血管生成反应。
PLoS One. 2013 Dec 30;8(12):e83755. doi: 10.1371/journal.pone.0083755. eCollection 2013.
10
Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells.评估羊水来源干细胞分化而来的内皮细胞。
Tissue Eng Part A. 2012 Jun;18(11-12):1123-31. doi: 10.1089/ten.TEA.2011.0392. Epub 2012 Mar 9.

引用本文的文献

1
Advancements in Mesenchymal Stem Cell-Based Therapy for Enhancing Arteriovenous Fistula Patency.基于间充质干细胞的疗法在提高动静脉内瘘通畅率方面的进展。
Int J Mol Sci. 2024 Nov 26;25(23):12719. doi: 10.3390/ijms252312719.
2
Harnessing the regenerative effects of human amniotic stem cells (hAFSCs) on restoring erectile function in a bilateral cavernous nerve crush (BCNC) injury rat model.利用人羊膜间充质干细胞(hAFSCs)的再生作用,在双侧海绵体神经挤压(BCNC)损伤大鼠模型中恢复勃起功能。
Stem Cell Res Ther. 2024 Nov 5;15(1):400. doi: 10.1186/s13287-024-03972-1.
3
Multipotent fetal stem cells in reproductive biology research.
生殖生物学研究中的多能胚胎干细胞。
Stem Cell Res Ther. 2023 Jun 7;14(1):157. doi: 10.1186/s13287-023-03379-4.
4
Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.推进非瘢痕性脱发的再生细胞疗法。
Pharmaceutics. 2022 Mar 10;14(3):612. doi: 10.3390/pharmaceutics14030612.
5
Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge.羊膜在组织工程和再生中的应用:百年挑战。
Stem Cell Res Ther. 2022 Jan 10;13(1):8. doi: 10.1186/s13287-021-02684-0.
6
ADSC-Based Cell Therapies for Musculoskeletal Disorders: A Review of Recent Clinical Trials.基于脂肪间充质干细胞的细胞疗法治疗肌肉骨骼系统疾病:近期临床试验研究综述。
Int J Mol Sci. 2021 Sep 30;22(19):10586. doi: 10.3390/ijms221910586.
7
An Comparison of Anti-Tumoral Potential of Wharton's Jelly and Bone Marrow Mesenchymal Stem Cells Exhibited by Cell Cycle Arrest in Glioma Cells (U87MG).《基于细胞周期停滞的胶质细胞瘤(U87MG)中 Wharton 氏胶和骨髓间充质干细胞抗肿瘤潜能的比较》
Pathol Oncol Res. 2021 Apr 8;27:584710. doi: 10.3389/pore.2021.584710. eCollection 2021.
8
Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration.间充质基质细胞及其分泌组:骨骼肌再生的新治疗前景
Front Bioeng Biotechnol. 2021 May 13;9:652970. doi: 10.3389/fbioe.2021.652970. eCollection 2021.
9
Comprehensive Profiling of Secretome Formulations from Fetal- and Perinatal Human Amniotic Fluid Stem Cells.全面分析胎牛和围产人羊膜干细胞分泌组制剂。
Int J Mol Sci. 2021 Apr 2;22(7):3713. doi: 10.3390/ijms22073713.
10
Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy.细胞疗法治疗严重肢体缺血:治疗严重糖尿病血管病变患者的优势、局限性和新视角。
Curr Diab Rep. 2021 Mar 2;21(3):11. doi: 10.1007/s11892-021-01378-4.